Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Molecular analysis of a CD19-negative diffuse large B-cell lymphoma.

Delage L, Manzoni D, Quinquenet C, Fontaine J, Maarek A, Chabane K, Mosnier I, Hayette S, Callet-Bauchu E, Grange B, Plesa A, Sujobert P.

Haematologica. 2019 Mar;104(3):e114-e116. doi: 10.3324/haematol.2018.203521. Epub 2018 Dec 13. No abstract available.

2.

Toll-like receptor expression and function differ between splenic marginal zone B cell lymphoma and splenic diffuse red pulp B cell lymphoma.

Verney A, Traverse-Glehen A, Callet-Bauchu E, Jallades L, Magaud JP, Salles G, Genestier L, Baseggio L.

Oncotarget. 2018 May 4;9(34):23589-23598. doi: 10.18632/oncotarget.25283. eCollection 2018 May 4.

3.

Usefulness of CD200 in the differential diagnosis of SDRPL, SMZL, and HCL.

Favre R, Manzoni D, Traverse-Glehen A, Verney A, Jallades L, Callet-Bauchu E, Sujobert P, Salles G, Baseggio L.

Int J Lab Hematol. 2018 Aug;40(4):e59-e62. doi: 10.1111/ijlh.12824. Epub 2018 Apr 16. No abstract available.

PMID:
29659173
4.

Exome sequencing identifies recurrent BCOR alterations and the absence of KLF2, TNFAIP3 and MYD88 mutations in splenic diffuse red pulp small B-cell lymphoma.

Jallades L, Baseggio L, Sujobert P, Huet S, Chabane K, Callet-Bauchu E, Verney A, Hayette S, Desvignes JP, Salgado D, Levy N, Béroud C, Felman P, Berger F, Magaud JP, Genestier L, Salles G, Traverse-Glehen A.

Haematologica. 2017 Oct;102(10):1758-1766. doi: 10.3324/haematol.2016.160192. Epub 2017 Jul 27.

5.

Absence of driver mutations in persistent polyclonal B-cell lymphocytosis with binucleated lymphocytes.

Tesson B, Huet S, Grange B, Jallades L, Baseggio L, Felman P, Traverse-Glehen A, Magaud JP, Lega JC, Bole-Feysot C, Salles G, Callet-Bauchu E, Sujobert P.

Blood. 2017 Sep 7;130(10):1267-1269. doi: 10.1182/blood-2017-03-776674. Epub 2017 Jul 5. No abstract available.

6.

Advances in the role of cytogenetic analysis in the molecular diagnosis of B-cell lymphomas.

Grange B, Callet-Bauchu E, Salles G, Sujobert P.

Expert Rev Mol Diagn. 2017 Jun;17(6):623-632. doi: 10.1080/14737159.2017.1327811. Epub 2017 May 15. Review.

PMID:
28480776
7.

MALT1 sequencing analyses in marginal zone B-cell lymphomas reveal mutations in the translocated MALT1 allele in an IGH-MALT1-positive MALT lymphoma.

Akyüz N, Albert-Konetzny N, Pott C, Callet-Bauchu E, Bokemeyer C, Murga Penas EM, Dierlamm J.

Leuk Lymphoma. 2017 Oct;58(10):2480-2484. doi: 10.1080/10428194.2017.1296144. Epub 2017 Mar 2. No abstract available.

PMID:
28278699
8.

Ibrutinib-Induced Lymphocytosis: Cytological Features.

Quintela A, Sujobert P, Callet-Bauchu E, Salles G, Baseggio L.

Acta Haematol. 2017;137(1):55-57. doi: 10.1159/000452437. Epub 2016 Dec 14. No abstract available.

PMID:
27960168
9.

Erratum to: BCR-ABL-positive acute myeloid leukemia: About one case treated with ponatinib.

Heiblig M, Bidet A, Callet-Bauchu E, Dumas PY, Chabane K, Salles G, Pigneux A.

Ann Hematol. 2017 Feb;96(2):337. doi: 10.1007/s00277-016-2879-4. No abstract available.

PMID:
27864605
10.

Comprehensive analysis of a myeloperoxidase-negative acute promyelocytic leukemia.

Heiblig M, Paubelle E, Plesa A, Geay MO, Manzoni D, Gazzo S, Tigaud I, Callet-Bauchu E, Huet S, Salles G, Thomas X, Hayette S, Sujobert P.

Blood. 2017 Jan 5;129(1):128-131. doi: 10.1182/blood-2016-09-741355. Epub 2016 Nov 8. No abstract available.

11.

Cytogenetics in the management of lymphomas and lymphoproliferative disorders in adults and children: an update by the Groupe francophone de cytogénétique hématologique (GFCH).

Lefebvre C, Callet-Bauchu E, Chapiro E, Nadal N, Penther D, Poirel HA.

Ann Biol Clin (Paris). 2016 Oct 1;74(5):568-587. Review.

PMID:
27707672
12.

Cytogenetics in the management of chronic lymphocytic leukemia: an update by the Groupe francophone de cytogénétique hématologique (GFCH).

Nguyen-Khac F, Borie C, Callet-Bauchu E, Eclache V, Struski S.

Ann Biol Clin (Paris). 2016 Oct 1;74(5):561-567. Review.

PMID:
27628190
13.

Splenic diffuse red pulp lymphoma has a distinct pattern of somatic mutations amongst B-cell malignancies.

Traverse-Glehen A, Verney A, Gazzo S, Jallades L, Chabane K, Hayette S, Coiffier B, Callet-Bauchu E, Ffrench M, Felman P, Berger F, Baseggio L, Salles G.

Leuk Lymphoma. 2017 Mar;58(3):666-675. doi: 10.1080/10428194.2016.1196813. Epub 2016 Jun 27.

PMID:
27347751
14.

Genetic differences between paediatric and adult Burkitt lymphomas.

Havelange V, Pepermans X, Ameye G, Théate I, Callet-Bauchu E, Barin C, Penther D, Lippert E, Michaux L, Mugneret F, Dastugue N, Raphaël M, Vikkula M, Poirel HA.

Br J Haematol. 2016 Apr;173(1):137-44. doi: 10.1111/bjh.13925. Epub 2016 Feb 16.

PMID:
26887776
15.

The peculiar 11q-gain/loss aberration reported in a subset of MYC-negative high-grade B-cell lymphomas can also occur in a MYC-rearranged lymphoma.

Havelange V, Ameye G, Théate I, Callet-Bauchu E, Lippert E, Luquet I, Raphaël M, Vikkula M, Poirel HA.

Cancer Genet. 2016 Mar;209(3):117-8. doi: 10.1016/j.cancergen.2015.12.005. Epub 2015 Dec 15. No abstract available.

PMID:
26776268
16.

Characterization of a de novo Supernumerary Neocentric Ring Chromosome Derived from Chromosome 7.

Louvrier C, Egea G, Labalme A, Des Portes V, Gazzo S, Callet-Bauchu E, Till M, Sanlaville D, Edery P, Schluth-Bolard C.

Cytogenet Genome Res. 2015;147(2-3):111-7. doi: 10.1159/000442265. Epub 2015 Dec 16.

PMID:
26669311
17.

CD180 overexpression in follicular lymphoma is restricted to the lymph node compartment.

Mestrallet F, Sujobert P, Sarkozy C, Traverse-Glehen A, Callet-Bauchu E, Magaud JP, Salles G, Baseggio L.

Cytometry B Clin Cytom. 2016 Sep;90(5):433-9. doi: 10.1002/cyto.b.21331. Epub 2015 Dec 11.

18.

[Graft-versus-host disease, a rare complication of lung transplantation].

Morisse-Pradier H, Nove-Josserand R, Philit F, Senechal A, Berger F, Callet-Bauchu E, Traverse-Glehen A, Maury JM, Grima R, Tronc F, Mornex JF.

Rev Pneumol Clin. 2016 Feb;72(1):101-7. doi: 10.1016/j.pneumo.2015.05.004. Epub 2015 Jul 21. Review. French.

PMID:
26209034
19.

A restricted IGHV gene repertoire in splenic marginal zone lymphoma is associated with autoimmune disorders.

Brisou G, Verney A, Wenner T, Baseggio L, Felman P, Callet-Bauchu E, Coiffier B, Berger F, Salles G, Traverse-Glehen A.

Haematologica. 2014 Oct;99(10):e197-8. doi: 10.3324/haematol.2014.107680. Epub 2014 Jul 4. No abstract available.

20.

Peripheral blood involvement in patients with follicular lymphoma: a rare disease manifestation associated with poor prognosis.

Sarkozy C, Baseggio L, Feugier P, Callet-Bauchu E, Karlin L, Seymour JF, Lebras L, Michallet AS, Offner F, Dumas O, Traverse-Glehen A, Ffrench M, Lopez-Guillermo A, Berger F, Coiffier B, Felman P, Salles G.

Br J Haematol. 2014 Mar;164(5):659-67. doi: 10.1111/bjh.12675. Epub 2013 Nov 26.

PMID:
24274024
21.

Long-term follow-up analysis of 100 patients with splenic marginal zone lymphoma treated with splenectomy as first-line treatment.

Lenglet J, Traullé C, Mounier N, Benet C, Munoz-Bongrand N, Amorin S, Noguera ME, Traverse-Glehen A, Ffrench M, Baseggio L, Felman P, Callet-Bauchu E, Brice P, Berger F, Salles G, Brière J, Coiffier B, Thieblemont C.

Leuk Lymphoma. 2014 Aug;55(8):1854-60. doi: 10.3109/10428194.2013.861067. Epub 2014 May 6.

PMID:
24206091
22.

Immunoarchitectural patterns in splenic marginal zone lymphoma: correlations with chromosomal aberrations, IGHV mutations, and survival. A study of 76 cases.

Traverse-Glehen A, Bachy E, Baseggio L, Callet-Bauchu E, Gazzo S, Verney A, Hayette S, Jallades L, Ffrench M, Salles G, Coiffier B, Felman P, Berger F.

Histopathology. 2013 May;62(6):876-93. doi: 10.1111/his.12092.

PMID:
23611359
23.

Chromosomal aberrations and their prognostic value in a series of 174 untreated patients with Waldenström's macroglobulinemia.

Nguyen-Khac F, Lambert J, Chapiro E, Grelier A, Mould S, Barin C, Daudignon A, Gachard N, Struski S, Henry C, Penther D, Mossafa H, Andrieux J, Eclache V, Bilhou-Nabera C, Luquet I, Terre C, Baranger L, Mugneret F, Chiesa J, Mozziconacci MJ, Callet-Bauchu E, Veronese L, Blons H, Owen R, Lejeune J, Chevret S, Merle-Beral H, Leblondon V; Groupe Français d'Etude de la Leucémie Lymphoïde Chronique et Maladie de Waldenström (GFCLL/MW); Groupe Ouest-Est d’étude des Leucémie Aiguës et Autres Maladies du Sang (GOELAMS); Groupe d’Etude des Lymphomes de l’Adulte (GELA).

Haematologica. 2013 Apr;98(4):649-54. doi: 10.3324/haematol.2012.070458. Epub 2012 Oct 12.

24.

Patterns of genomic aberrations suggest that Burkitt lymphomas with complex karyotype are distinct from other aggressive B-cell lymphomas with MYC rearrangement.

Havelange V, Ameye G, Théate I, Callet-Bauchu E, Mugneret F, Michaux L, Dastugue N, Penther D, Barin C, Collonge-Rame MA, Baranger L, Terré C, Nadal N, Lippert E, Laï JL, Cabrol C, Tigaud I, Herens C, Hagemeijer A, Raphael M, Libouton JM, Poirel HA; GFCH (Groupe Francophone de Cytogénétique Hématologique).

Genes Chromosomes Cancer. 2013 Jan;52(1):81-92. doi: 10.1002/gcc.22008. Epub 2012 Sep 25.

PMID:
23012230
25.

In non-follicular lymphoproliferative disorders, IGH/BCL2-fusion is not restricted to chronic lymphocytic leukaemia.

Baseggio L, Geay MO, Gazzo S, Berger F, Traverse-Glehen A, Ffrench M, Hayette S, Callet-Bauchu E, Verney A, Morel D, Jallades L, Magaud JP, Salles G, Felman P.

Br J Haematol. 2012 Aug;158(4):489-98. doi: 10.1111/j.1365-2141.2012.09178.x. Epub 2012 Jun 12.

PMID:
22686190
26.

MicroRNA expression profile in splenic marginal zone lymphoma.

Bouteloup M, Verney A, Rachinel N, Callet-Bauchu E, Ffrench M, Coiffier B, Magaud JP, Berger F, Salles GA, Traverse-Glehen A.

Br J Haematol. 2012 Jan;156(2):279-81. doi: 10.1111/j.1365-2141.2011.08848.x. Epub 2011 Sep 9. No abstract available.

PMID:
21902683
27.

Identification of proteomic signatures of mantle cell lymphoma, small lymphocytic lymphoma, and marginal zone lymphoma biopsies by surface enhanced laser desorption/ionization-time of flight mass spectrometry.

Rolland D, Bouamrani A, Houlgatte R, Barbarat A, Ramus C, Arlotto M, Ballester B, Berger F, Felman P, Callet-Bauchu E, Baseggio L, Traverse-Glehen A, Brugière S, Garin J, Coiffier B, Berger F, Thieblemont C.

Leuk Lymphoma. 2011 Apr;52(4):648-58. doi: 10.3109/10428194.2010.549256. Epub 2011 Jan 11.

PMID:
21438832
28.

Specific chromosomal IG translocations have different prognoses in chronic lymphocytic leukemia.

Nguyen-Khac F, Chapiro E, Lesty C, Grelier A, Luquet I, Radford-Weiss I, Lefebvre C, Fert-Ferrer S, Callet-Bauchu E, Lippert E, Raggueneau V, Michaux L, Barin C, Collonge-Rame MA, Mugneret F, Eclache V, Taviaux S, Dastugue N, Richebourg S, Struski S, Talmant P, Baranger L, Gachard N, Gervais C, Quilichini B, Settegrana C, Maloum K, Davi F, Merle-Béral H.

Am J Blood Res. 2011;1(1):13-21. Epub 2011 Apr 15.

29.

Relevance of a scoring system including CD11c expression in the identification of splenic diffuse red pulp small B-cell lymphoma (SRPL).

Baseggio L, Traverse-Glehen A, Callet-Bauchu E, Morel D, Magaud JP, Berger F, Salles G, Felman P.

Hematol Oncol. 2011 Mar;29(1):47-51. doi: 10.1002/hon.957.

PMID:
20677173
30.

Deregulation of the telomerase reverse transcriptase (TERT) gene by chromosomal translocations in B-cell malignancies.

Nagel I, Szczepanowski M, Martín-Subero JI, Harder L, Akasaka T, Ammerpohl O, Callet-Bauchu E, Gascoyne RD, Gesk S, Horsman D, Klapper W, Majid A, Martinez-Climent JA, Stilgenbauer S, Tönnies H, Dyer MJ, Siebert R.

Blood. 2010 Aug 26;116(8):1317-20. doi: 10.1182/blood-2009-09-240440. Epub 2010 May 11.

31.

Lymphoma recurrence 5 years or later following diffuse large B-cell lymphoma: clinical characteristics and outcome.

Larouche JF, Berger F, Chassagne-Clément C, Ffrench M, Callet-Bauchu E, Sebban C, Ghesquières H, Broussais-Guillaumot F, Salles G, Coiffier B.

J Clin Oncol. 2010 Apr 20;28(12):2094-100. doi: 10.1200/JCO.2009.24.5860. Epub 2010 Mar 22.

PMID:
20308668
32.

Hairy cell leukaemia-variant and splenic red pulp lymphoma: a single entity?

Traverse-Glehen A, Baseggio L, Callet-Bauchu E, Ffrench M, Coiffier B, Salles G, Felman P, Berger F.

Br J Haematol. 2010 Jul;150(1):113-6. doi: 10.1111/j.1365-2141.2010.08153.x. Epub 2010 Mar 11. No abstract available.

PMID:
20230408
33.

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study.

Pott C, Hoster E, Delfau-Larue MH, Beldjord K, Böttcher S, Asnafi V, Plonquet A, Siebert R, Callet-Bauchu E, Andersen N, van Dongen JJ, Klapper W, Berger F, Ribrag V, van Hoof AL, Trneny M, Walewski J, Dreger P, Unterhalt M, Hiddemann W, Kneba M, Kluin-Nelemans HC, Hermine O, Macintyre E, Dreyling M.

Blood. 2010 Apr 22;115(16):3215-23. doi: 10.1182/blood-2009-06-230250. Epub 2009 Dec 23.

34.

CD5 expression identifies a subset of splenic marginal zone lymphomas with higher lymphocytosis: a clinico-pathological, cytogenetic and molecular study of 24 cases.

Baseggio L, Traverse-Glehen A, Petinataud F, Callet-Bauchu E, Berger F, Ffrench M, Couris CM, Thieblemont C, Morel D, Coiffier B, Salles G, Felman P.

Haematologica. 2010 Apr;95(4):604-12. doi: 10.3324/haematol.2009.011049. Epub 2009 Dec 16.

35.

The t(14;18)(q32;q21)/IGH-MALT1 translocation in MALT lymphomas contains templated nucleotide insertions and a major breakpoint region similar to follicular and mantle cell lymphoma.

Murga Penas EM, Callet-Bauchu E, Ye H, Gazzo S, Berger F, Schilling G, Albert-Konetzny N, Vettorazzi E, Salles G, Wlodarska I, Du MQ, Bokemeyer C, Dierlamm J.

Blood. 2010 Mar 18;115(11):2214-9. doi: 10.1182/blood-2009-08-236265. Epub 2009 Nov 25.

36.

Biallelic inactivation of TRAF3 in a subset of B-cell lymphomas with interstitial del(14)(q24.1q32.33).

Nagel I, Bug S, Tönnies H, Ammerpohl O, Richter J, Vater I, Callet-Bauchu E, Calasanz MJ, Martinez-Climent JA, Bastard C, Salido M, Schroers E, Martin-Subero JI, Gesk S, Harder L, Majid A, Dyer MJ, Siebert R.

Leukemia. 2009 Nov;23(11):2153-5. doi: 10.1038/leu.2009.149. Epub 2009 Aug 20. No abstract available.

PMID:
19693093
37.

Identification of a perinuclear positioning element in human subtelomeres that requires A-type lamins and CTCF.

Ottaviani A, Schluth-Bolard C, Rival-Gervier S, Boussouar A, Rondier D, Foerster AM, Morere J, Bauwens S, Gazzo S, Callet-Bauchu E, Gilson E, Magdinier F.

EMBO J. 2009 Aug 19;28(16):2428-36. doi: 10.1038/emboj.2009.201. Epub 2009 Jul 30.

38.

Gain of the short arm of chromosome 2 (2p) is a frequent recurring chromosome aberration in untreated chronic lymphocytic leukemia (CLL) at advanced stages.

Chapiro E, Leporrier N, Radford-Weiss I, Bastard C, Mossafa H, Leroux D, Tigaud I, De Braekeleer M, Terré C, Brizard F, Callet-Bauchu E, Struski S, Veronese L, Fert-Ferrer S, Taviaux S, Lesty C, Davi F, Merle-Béral H, Bernard OA, Sutton L, Raynaud SD, Nguyen-Khac F.

Leuk Res. 2010 Jan;34(1):63-8. doi: 10.1016/j.leukres.2009.03.042. Epub 2009 Apr 29.

PMID:
19406473
39.

Comprehensive analysis of GST-pi expression in B-cell lymphomas: Correlation with histological subtypes and survival.

Thieblemont C, Rolland D, Baseggio L, Felman P, Gazzo S, Callet-Bauchu E, Traverse-Glehen A, Houlgatte R, Fu K, Weisenburger D, De Jong D, Jaffe ES, Rosenwald A, Ott G, Coiffier B, Berger F.

Leuk Lymphoma. 2008 Jul;49(7):1403-6. doi: 10.1080/10428190802094245. No abstract available.

40.

The most frequent t(14;19)(q32;q13)-positive B-cell malignancy corresponds to an aggressive subgroup of atypical chronic lymphocytic leukemia.

Chapiro E, Radford-Weiss I, Bastard C, Luquet I, Lefebvre C, Callet-Bauchu E, Leroux D, Talmant P, Mozziconacci MJ, Mugneret F, Struski S, Raynaud S, Andrieux J, Barin C, Jotterand M, Mossafa H, Ramond S, Terré C, Lippert E, Berger F, Felman P, Merle-Béral H, Bernard OA, Davi F, Berger R, Nguyen-Khac F.

Leukemia. 2008 Nov;22(11):2123-7. doi: 10.1038/leu.2008.102. Epub 2008 May 1. No abstract available.

PMID:
18449207
41.

Splenic marginal zone lymphoma proposals for a revision of diagnostic, staging and therapeutic criteria.

Matutes E, Oscier D, Montalban C, Berger F, Callet-Bauchu E, Dogan A, Felman P, Franco V, Iannitto E, Mollejo M, Papadaki T, Remstein ED, Salar A, Solé F, Stamatopoulos K, Thieblemont C, Traverse-Glehen A, Wotherspoon A, Coiffier B, Piris MA.

Leukemia. 2008 Mar;22(3):487-95. Epub 2007 Dec 20. Review.

PMID:
18094718
42.

[Pulmonary MALT lymphoma].

Cottin V, Callet-Bauchu E, Traclet J, Cordier JF.

Rev Prat. 2007 Oct 15;57(15):1636. French. No abstract available.

PMID:
18080419
43.

Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia.

Poncet D, Belleville A, t'kint de Roodenbeke C, Roborel de Climens A, Ben Simon E, Merle-Beral H, Callet-Bauchu E, Salles G, Sabatier L, Delic J, Gilson E.

Blood. 2008 Feb 15;111(4):2388-91. Epub 2007 Dec 12.

44.

Angioimmunoblastic T-cell lymphoma: clinical and laboratory features at diagnosis in 77 patients.

Lachenal F, Berger F, Ghesquières H, Biron P, Hot A, Callet-Bauchu E, Chassagne C, Coiffier B, Durieu I, Rousset H, Salles G.

Medicine (Baltimore). 2007 Sep;86(5):282-92.

45.

Identification of a novel e8/a4 BCR/ABL fusion transcript in a case of a transformed Sézary syndrome.

Callet-Bauchu E, Salles G, Gazzo S, Dalle S, Berger F, Hayette S.

Haematologica. 2007 Sep;92(9):1277-8.

46.

Detailed characterization of 7q deletions by multicolor banding (mBAND) in marginal zone cell lymphoma.

Gazzo S, Chudoba I, Traverse-Glehen A, Baseggio L, Felman P, Berger F, Salles G, Hayette S, Magaud JP, Callet-Bauchu E.

Cancer Genet Cytogenet. 2007 Jun;175(2):159-65.

PMID:
17556073
47.

A comprehensive genetic and histopathologic analysis identifies two subgroups of B-cell malignancies carrying a t(14;19)(q32;q13) or variant BCL3-translocation.

Martín-Subero JI, Ibbotson R, Klapper W, Michaux L, Callet-Bauchu E, Berger F, Calasanz MJ, De Wolf-Peeters C, Dyer MJ, Felman P, Gardiner A, Gascoyne RD, Gesk S, Harder L, Horsman DE, Kneba M, Küppers R, Majid A, Parry-Jones N, Ritgen M, Salido M, Solé F, Thiel G, Wacker HH, Oscier D, Wlodarska I, Siebert R.

Leukemia. 2007 Jul;21(7):1532-44. Epub 2007 May 10.

PMID:
17495977
48.

Promoter methylation of PARG1, a novel candidate tumor suppressor gene in mantle-cell lymphomas.

Ripperger T, von Neuhoff N, Kamphues K, Emura M, Lehmann U, Tauscher M, Schraders M, Groenen P, Skawran B, Rudolph C, Callet-Bauchu E, van Krieken JH, Schlegelberger B, Steinemann D.

Haematologica. 2007 Apr;92(4):460-8.

49.

Analysis of BCL-6, CD95, PIM1, RHO/TTF and PAX5 mutations in splenic and nodal marginal zone B-cell lymphomas suggests a particular B-cell origin.

Traverse-Glehen A, Verney A, Baseggio L, Felman P, Callet-Bauchu E, Thieblemont C, Ffrench M, Magaud JP, Coiffier B, Berger F, Salles G.

Leukemia. 2007 Aug;21(8):1821-4. Epub 2007 May 3. No abstract available.

PMID:
17476282
50.

The translocations t(6;18;11)(q24;q21;q21) and t(11;14;18)(q21;q32;q21) lead to a fusion of the API2 and MALT1 genes and occur in MALT lymphomas.

Murga Penas EM, Callet-Bauchu E, Ye H, Hinz K, Albert N, Copie-Bergman C, Gazzo S, Berger F, Salles G, Bokemeyer C, Du MQ, Dierlamm J.

Haematologica. 2007 Mar;92(3):405-9.

Supplemental Content

Loading ...
Support Center